B40.81
Blastomycotic meningoencephalitis
Clinical Classification Guidelines
Inclusion Terms
- Meningomyelitis due to blastomycosis
Medical Intelligence & Overview
Blastomycotic meningoencephalitis is a rare but serious fungal infection affecting the brain and its surrounding tissues. Caused by the fungus Blastomyces dermatitidis, this condition can lead to significant neurological symptoms and complications if not diagnosed and treated promptly. It is classified under ICD-10 code B40.81, indicating meningeal and cerebral involvement due to blastomycosis. Understanding this disease is vital for early recognition and management, especially in individuals with compromised immune systems or those residing in endemic areas.
Causes & Symptoms
Clinical Causes: Infection with the fungus Blastomyces dermatitidis, typically found in soil and decaying organic matter. Inhalation of airborne spores from environments contaminated with the fungus. Spread from a primary blastomycosis infection in lungs or other parts of the body to the central nervous system. Immunosuppression, such as HIV/AIDS, organ transplant, or ongoing chemotherapy, increasing susceptibility. Geographical exposure, particularly in regions like the southeastern United States, Ohio and Mississippi River valleys, and parts of Canada.
Key Symptoms: Headache, often severe and persistent. Fever and chills, indicating systemic infection. Neck stiffness and sensitivity to light (photophobia). Altered mental status, including confusion or drowsiness. Seizures or convulsions in advanced cases. Nausea and vomiting. Focal neurological deficits, such as weakness or numbness. Visual disturbances or changes in consciousness. Signs of increased intracranial pressure, like vomiting or papilledema.
Diagnostic & Treatment
Diagnosis Path: Diagnosing blastomycotic meningoencephalitis involves a combination of clinical assessment and laboratory tests. Medical professionals may perform:
Treatment Protocols: Managing blastomycotic meningoencephalitis typically involves antifungal therapy, which aims to eradicate the fungal infection and reduce neurological damage. Treatment strategies include:
Clinical Advice & FAQs
Billing Guidance
Is B40.81 a billable ICD-10 code?
Yes, B40.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B40.81?
Clinical documentation must specify the nature of Blastomycotic meningoencephalitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference